Skip to content
10-Q

Quarterly Report

Codiak BioSciences, Inc.

0000950170-22-007860

← back to feed
Filed
May 5, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 29, 2022 22.49M sh
Capex Q1 2022 · Mar 31, 2022 $182K
Capex Q1 2022 · Mar 31, 2021 $1.53M
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$20.85M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$19.64M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $56.49M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $76.94M
Cash And Equivalents Q1 2022 · Mar 31, 2021 $130.27M
Stockholders Equity Q1 2022 · Mar 31, 2022 $48.38M
Stockholders Equity Q1 2022 · Dec 31, 2021 $53.51M
Stockholders Equity Q1 2022 · Mar 31, 2021 $68.72M
Stockholders Equity Q1 2022 · Dec 31, 2020 $14.57M
Current Liabilities Q1 2022 · Mar 31, 2022 $11.54M
Current Liabilities Q1 2022 · Dec 31, 2021 $27.17M
Total Liabilities Q1 2022 · Mar 31, 2022 $101.69M
Total Liabilities Q1 2022 · Dec 31, 2021 $118.17M
Current Assets Q1 2022 · Mar 31, 2022 $69.91M
Current Assets Q1 2022 · Dec 31, 2021 $90.17M
Total Assets Q1 2022 · Mar 31, 2022 $150.07M
Total Assets Q1 2022 · Dec 31, 2021 $171.67M
Sga Expense Q1 2022 · Mar 31, 2022 $6.71M
Sga Expense Q1 2022 · Mar 31, 2021 $6.59M
Rd Expense Q1 2022 · Mar 31, 2022 $14.25M
Rd Expense Q1 2022 · Mar 31, 2021 $16.55M
Net Income Q1 2022 · Mar 31, 2022 −$8.03M
Net Income Q1 2022 · Mar 31, 2021 −$10.31M
Operating Income Q1 2022 · Mar 31, 2022 −$8.25M
Operating Income Q1 2022 · Mar 31, 2021 −$9.95M
Revenue Q1 2022 · Mar 31, 2022 $12.7M
Revenue Q1 2022 · Mar 31, 2021 $13.19M
Stock Issued Q1 2022 · Feb 17, 2021 3.16M sh
Stock Issued Q1 2022 · Oct 16, 2020 5.5M sh